ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,587, issued on Dec. 30, was assigned to ASETLLAS PHARMA INC. (Tokyo).
"Crystal of indocyanine compound" was invented by Hiroyuki Yamashita (Tokyo) and Kouji Yamazaki (Tokyo).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is a crystal of 3-(3-{[3-(cyclomaltoheptaos-21-O-yl)propyl]amino}-3-oxopropyl)-2-{(1E)-2-[(3E)-3-{(2E)-2-[3-(3-{[3-(cyclomaltoheptaos-21-O-yl)propyl]amino}-3-oxopropyl)-1,1-dimethyl-1,3-dihydro-2H-benzo[e]indol-2-ylidene]ethylidene}-2-methoxycyclohex-1-en-1-yl]ethen-1-yl}-1,1-dimethyl-1H-benzo[e]indol-3-ium chloride."
The patent was filed on Nov. 25, 2020, under Application No. 17/780,138.
*For further informa...